Liao et al. reported that knockdown of securin reduced motility, invasion, and metastasis of BC cells by suppressing Rho guanine nucleotide exchange factor-H1 (GEF-H1) expression and RhoA activation. The gene discussed is PTTG1; the disease is breast cancer.